In partnership with

Ugly quarter, tasty payout. If you like income, take a small first sip here, then only pour more if the next couple of updates show the business steadying. Treat pops like happy hour, grab a little profit, and if the story goes flat again, close the tab.

Fandom’s Winning Formula: Safer Content, 50% Savings, More Ad Revenue

The secret’s out.

Fandom—the world’s largest fan platform with 350M monthly visitors—faced a massive challenge: ensuring safety, quality, and monetization across 250,000 wikis.

Their solution? AI-powered transformation with Coactive.

Join our exclusive webinar on November 18 (9:15 am PT / 12:15 pm ET) to see how Fandom revolutionized content moderation and ad monetization.

Discover the results:
• 74% fewer manual moderation hours, boosting team morale
• 50% cost savings by automating image reviews
• Higher ad revenue from brand-safe, quality content

Learn how to turn your content into a monetizable growth engine that delights users and cuts costs.

Register today to join live or watch on demand.

Futures at a Glance📈

Green this morning as the Senate inches toward a shutdown truce, taking some fear out. AI bellwethers are perking up after last week’s valuation freak-out, while the data void (thanks, shutdown) keeps traders leaning on headlines over hard prints. Looks to be a good day, at least.

Want to make sure you never miss a pre-market alert?

Elite Trade Club now offers text alerts — so you get trending stocks and market-moving news sent straight to your phone before the bell.

Email’s great. Texts are faster.

You’ll be first in line when the market starts moving.

What to Watch

Premarket Earnings:

  • Barrick Mining [B]

  • Venture Global [VG]

  • Tyson Foods [TSN]

  • KE Holdings [BEKE]

Aftermarket Earnings:

  • CoreWeave [CRWV]

  • Occidental Petroleum [OXY]

  • Rocket Lab [RKLB]

  • AST SpaceMobile [ASTS]

  • Sabesp [SBS]

Economic Reports:

None scheduled.

Internet Services

Grab Keeps Grabbing, And Jakarta Might Hand It A Bigger Plate

Grab Holdings Ltd (NASDAQ: GRAB) is getting love from analysts and a side of merger chatter in Indonesia, where officials floated the idea of a tie-up with GoTo. The delivery/ride giant could end up with an even bigger slice of Southeast Asia’s takeout and taxi pie.

Even without extra helpings, its latest results showed the core business isn’t living on promo coupons anymore, as growth plus profits is a combo meal investors can digest.

Of course, regulators don’t hand out monopolies like napkins. Any deal would come with strings, and rivals rarely go quietly. But the bigger story is simple: more orders, more rides, and fewer discounts is how this model finally works. If the government nudges consolidation, that’s gravy; if not, steady blocking and tackling still moves the chains.

For now, think of Grab as the dependable weeknight dinner, maybe not fine dining, but it shows up hot and on time. If the merger talk turns real, expect a burst of spicy headlines; if it fizzles, you still own a platform that keeps adding restaurants and riders.

My Take For You: Starter portion only. Add on pullbacks, especially if management keeps tightening spend while volumes grow.

My Verdict: Accumulate on dips and upgrade to entrée if consolidation actually lands.

Biotech

Gilead’s Good News/Bad News Tour Still Finds A Beat

Gilead Sciences Inc’s (NASDAQ: GILD) week looks like a mixed playlist here. There’s a catchy chorus from steady HIV sales and cleaner earnings, plus a skipped track or two in oncology.

The net effect is not a banger, not a flop, just a head-nodder with decent bass. When a pipeline has both green lights and potholes, the market usually hums the tune of patience.

Here, the base business throws off cash, the dividend keeps showing up like clockwork, and the balance sheet isn’t exactly living on energy drinks. That buys time for the R&D team to sort which programs are album material versus demo tapes.

The stock has had a nice run, so don’t expect crowd-surfing every headline day, but dependable catalog revenue can keep the lights on while the next single gets polished.

Bigger picture: you’re paying for a mix of proven franchises plus optionality. If one of the late-stage tracks hits, great; if not, the royalty checks still clear. That’s not thrilling, but it is how grown-up pharma compounds.

My Take For You: Fine for a core slot if you like steady checks while you wait. If you’re here for fireworks, size it smaller and trade around the news.

My Verdict: Hold/accumulate for income and patience, and trade a bit on pipeline pops.

More Gains. Less Risk. (Sponsored)

It’s not trading. It’s not mining. It’s something far smarter.

Called “Bitcoin Skimming,” this little-known method has outperformed Bitcoin by margins most would call impossible — 6x, 9x, even 22x gains in past rallies.

It doesn’t rely on buying dips or timing tops.

It works by capturing profit from Bitcoin’s volatility itself — the very thing most investors fear.

And now, a former hedge fund pro is explaining it all in plain English — in a free, limited-time video that could change how you think about crypto forever.

No extra coins. No extreme risk. Just a smarter approach for the next big move.

Click here to watch before it’s gone.

Consumer Staples

Molson Coors Spills A Pint, Tries Not To Waste The Keg

Impairment charges, cut guidance, and a net loss. Yeah, that’s a warm flat beer of a quarter. Molson Coors Beverage Co (NYSE: TAP) says restructuring and brand work, but investors mostly tasted foam. When a legacy brewer hits turbulence, the debate turns into value versus value trap with a frothy dividend head.

There’s a path to a colder pour: trim the underperformers, focus on premium and non-beer, and keep the cost taps under control. If management actually sticks to that recipe, margins can sober up, and the balance sheet can pay you to wait.

But it’s still a bar fight for share, and input costs don’t always play nice. Investors need proof that the new menu is bringing regulars back, not just happy-hour tourists.

If you’re thinking cheap for a reason, you’re not wrong. If you’re thinking paid to be patient, you’re not wrong either. The trick is not confusing a low price with easy upside, as turnarounds pour slowly.

My Take For You: Income hunters can sip, not chug. Use bounces to trim and dips only to top off a modest glass. Momentum folks, take a look at a different pub.

My Verdict: Cautious hold for yield and gradual fix-up; speculative buy only if you see real progress in mix and margins quarter after quarter.

Poll: The biggest red flag in financial advice is when someone says…

Login or Subscribe to participate

Movers and Shakers

Rumble [RUM]: Premarket Move: +21%

Narrower losses and a little ARPU glow-up have the platform flexing like it finally found the monetize button. Fewer users, more dollars per head means less crowd, bigger tab.

Just remember this is still a small-cap attention economy play, and headlines and creator drama can spin it like a fidget toy.

My Take: Trade it, don’t tattoo it. Starter buy only, skim quick green, and step aside if the buzz fades.

Lumentum [LITE]: Premarket Move: +7%

Optics names are still getting love, and this one’s been sprinting like it stole Wi-Fi. The story is AI plumbing and cloud demand, which is very in, very shiny.

But after a moonwalk like this, even good news can get the slow clap. Valuation nosebleeds don’t care about your FOMO.

My Take: If you must, just buy a little bit. Think kid-size. Add only on calm dips that hold, and don’t chase if it’s already vertical.

Centene [CNC]: Premarket Move: −5%

Managed care is having a feeling week with costs, regs, and margin math all arguing in the group chat. Yes, the top line looks sturdy, but the market’s grumbling about what it takes to keep it.

These aren’t meme swings, they’re actuarial mood swings, which means slower to fix and less fun to ride.

My Take: Let it settle into a lower spot. If it firms up above your line in the sand, a small position makes sense, but if it keeps leaking, save the dry powder.

Rare Market Moves (Sponsored)

Some stocks don’t just rise — they explode.

A new report reveals 5 stocks with the potential to gain 100%+ in the next 12 months, backed by strong fundamentals and bullish technical signals.

Past picks from this team have soared +175%, +498%, even +673%.¹

This free report gives direct access to the names and tickers — no fluff, just high-upside plays.

Available free until midnight tonight.

Everything Else

  • SoftBank-backed eyewear darling Lenskart had a bumpy debut despite an oversubscribed IPO, reminding everyone that hot listings can still wobble out of the gate.

  • Beijing signaled a thaw with The Hague, lifting Wingtech/Nexperia sentiment and hinting chip diplomacy isn’t totally frozen.

  • In a broader de-escalation move, China paused some critical mineral curbs to the U.S., which is a small but market-friendly trade truce breadcrumb.

  • Politics watch: as the shutdown drags on, talk of taking fresh aim at Obamacare adds headline risk for health-care names and insurers.

  • Meanwhile, the AI boom still needs a mountain of money; Big Tech is mixing bonds and partners to keep the data-center buildout humming.

That’s all for today. Thank you for reading. If you have any feedback, please reply to this email.

Best Regards,

— Adam Garcia
Elite Trade Club

Click here to get our daily newsletter straight to your cell for free.

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.

Keep Reading

No posts found